Form 4: Arcellx CFO Michelle Gilson Executes Stock Transactions Under 10b5-1 Plan

Arcellx's Chief Financial Officer, Michelle Gilson, executed multiple stock transactions, including both option exercises and sales, under a pre-arranged 10b5-1 trading plan.

Summary

• Michelle Gilson, the Chief Financial Officer of Arcellx, Inc., engaged in several transactions involving the company's stock on November 8, 2024.
• These transactions included the exercise of stock options to acquire 7,200 shares at a price of $8.66 per share.
• Gilson also sold a total of 12,354 shares of common stock at weighted average prices ranging from $100.2633 to $102.3348.
• The sales were executed under a pre-existing Rule 10b5-1 trading plan, which was initially established on December 18, 2023, and later modified on March 27, 2024.
• Following these transactions, Gilson directly owns 1,761 shares of common stock and 81,315 stock options.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative in itself. It is a neutral event.

Industry Context

This is a routine filing related to insider trading activity and is common for executives of publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies, such as those in the biotechnology sector like Amgen, Gilead Sciences, and Regeneron Pharmaceuticals.
• These plans allow insiders to sell shares at predetermined times and prices, mitigating the risk of insider trading allegations.
• The reported transactions are typical for executives who receive stock options as part of their compensation packages.

Stakeholder Impact

• The transactions may have a minor impact on the stock price, but are unlikely to cause significant fluctuations as they were pre-planned.
• Shareholders may view the transactions as a normal part of executive compensation.

Key Dates

Keywords

Arcellx, Michelle Gilson, stock transactions, Rule 10b5-1, stock options, insider trading, SEC Form 4